...
首页> 外文期刊>Química Nova >Characterization and in vitro release of cyclosporine-A from poly(D,L-lactide-co-glycolide implants obtained by solvent/extraction evaporation
【24h】

Characterization and in vitro release of cyclosporine-A from poly(D,L-lactide-co-glycolide implants obtained by solvent/extraction evaporation

机译:从溶剂/萃取蒸发法获得的聚(D,L-丙交酯-共-乙交酯)植入物中表征和体外释放环孢素A

获取原文

摘要

Cyclosporine-A-loaded PLGA implants were developed intended for ocular route. Implants were prepared using solvent extraction/evaporation technique followed by casting of the cake into rods in a heated surface. XRD patterns showed that cyclosporine-A was completely incorporated into PLGA. FTIR and DSC results indicated alterations on drug molecular conformation aiming to reach the most stable thermodynamic conformation at polymer/drug interface. Implants provided controlled/sustained in vitro release of the drug. During the first 7 weeks, the drug release was controlled by the diffusion of the cyclosporine-A; and between 7-23 week period, the drug diffusion and degradation of PLGA controlled the drug release.
机译:装载了环孢霉素A的PLGA植入物旨在用于眼部手术。使用溶剂萃取/蒸发技术制备植入物,然后将滤饼浇铸到加热表面的棒中。 XRD图谱表明环孢菌素-A完全掺入PLGA。 FTIR和DSC结果表明药物分子构象发生变化,旨在在聚合物/药物界面处达到最稳定的热力学构象。植入物提供了药物的受控/持续体外释放。在最初的7周内,药物的释放受环孢菌素A的扩散控制。在7-23周期间,PLGA的药物扩散和降解控制了药物的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号